Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma
MacLean P. Nasrallah(University of Pennsylvania), Jennifer J.D. Morrissette(University of Pennsylvania), Christopher D. Watt(University of Pennsylvania), Robert Daber(University of Pennsylvania), Zev A. Binder(University of Pennsylvania), Steven Brem(University of Pennsylvania), Derek A. Oldridge(California University of Pennsylvania), Donald M. O’Rourke(University of Pennsylvania), Shrey Sukhadia(Dartmouth–Hitchcock Medical Center), Eva Klinman(University of Pennsylvania), Jacquelyn J. Roth(UPMC Hillman Cancer Center), Jianhua Zhao(Southwest Petroleum University), David Lieberman(University of Pennsylvania), Arati Desai(University of Pennsylvania)
Cited by 31
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination
|Science Immunology|2021|729
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations
|Nature Genetics|2015|563